cronos group glp-1 receptor agonists weight management diabetes treatments New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within The Role of GLP-1RA Medications

Padia SH, Kemp BA, Howell NL, Siragy HM, Fournie-Zaluski MC, Roques BP, Carey RM

,

Studies comparing combination therapy to individual peptides show enhanced reduction of inflammatory markers and improved preservation of tissue function, particularly in chronic inflammatory conditions where both protection and repair are needed simultaneously

Jun 6, 2016 all ABOUT EYES

Evidence note: The mechanisms of ipamorelin and CJC-1295 are grounded in real GH physiology, but high-quality, peer-reviewed human clinical trials on the specific combination and on long-term outcomes are limited

[1] It is most commonly evaluated in combination with CJC-1295, as the two compounds target complementary receptor pathways to support natural growth hormone production while preserving physiological pulsatility